WealthOrbit is an AI-powered financial intelligence platform that provides real-time market data, IPO tracking with GMP, mutual fund analysis, stock screening, crypto prices, and AI-driven insights for Indian investors.

Yes, WealthOrbit offers a free plan with basic market data, a 5-stock watchlist, and 2 AI queries per day. Premium plans start at ₹199/month for advanced features.

Does WealthOrbit provide financial advice?

No. WealthOrbit provides market data and AI-generated analysis for informational and educational purposes only. It is not a SEBI-registered investment advisor and does not provide financial advice.

GMP (Grey Market Premium) is the unofficial premium at which IPO shares trade before listing. It is sourced from grey market estimates and is not a reliable indicator of listing performance.

What markets does WealthOrbit cover?

WealthOrbit covers Indian markets (NSE, BSE) including stocks, IPOs, mutual funds, and ETFs. It also provides global indices, cryptocurrency data, commodities (gold, silver, oil), and forex rates.

Sun Pharmaceutical Industries Ltd (SUNPHARMA)

Sun Pharmaceutical Industries Ltd share price, charts, financials, and analysis on WealthOrbit.

Sun Pharmaceutical Industries Ltd

Healthcarelarge_cap

SUNPHARMA · BSE · Drug Manufacturers - Specialty & Generic

₹1,879.6

-0.14%₹-2.55

Live · Prev close ₹1,882.15

Market Cap

₹4.52 L

P/E

41.37x

P/B

5.8x

ROE

17.05%

ROCE

10.93%

D/E

0.07

Div Yield

97%

Book Val

₹324.46

Price Ranges

Day Low: ₹1,872.4Day High: ₹1,892

52W Low: ₹1,547.2552W High: ₹1,917.15

Price Chart

No chart data available

Returns

Analysis· Based on latest data

Pros

Strong ROE of 17.1% — above 15% threshold
Low debt-to-equity ratio of 0.07 — conservatively funded
Attractive dividend yield of 97.00%
Healthy operating margin of 26.2%

Cons

High P/B ratio of 5.8x — above book value premium

* Auto-generated from financial ratios. Do your own analysis before investing.

Company Info

ISIN

INE044A01036

Series

Industry

Drug Manufacturers - Specialty & Generic

Listed

3 Jan 2000

Mumbai, India

Face Val

₹1

Largest pharma company

Fundamentals

TTM P/E41.37x

P/B Ratio5.8x

EPS (TTM)₹45.5

ROE17.05%

ROCE10.93%

Debt / Equity0.07

Revenue (TTM)₹56.8 K

Net Profit (TTM)₹10.9 K

Promoter Holding55.62%